Description
Venetoclax is used to treat chronic lymphocytic leukemia or small lymphocytic leukemia in adults with or without 17p deletion (a specific genetic marker). Venetoclax is sometimes used in combination with rituximab to treat these conditions. Venetoclax is also used in combination with azacitidine, decitabine, or cytarabine to treat acute myeloid leukemia. This combination is for use in adults who are 75 years or older, or who cannot use standard chemotherapy due to other medical conditions. Venetoclax is sometimes given after other treatments have failed. Venetoclax may also be used for purposes not listed in this medication guide.https://www.drugs.com/mtm/venetoclax.html
